{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:29:29Z","timestamp":1791584969243,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004386","name":"Universiti Malaya","doi-asserted-by":"publisher","award":["UMREG030-2023"],"award-info":[{"award-number":["UMREG030-2023"]}],"id":[{"id":"10.13039\/501100004386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-53191-2","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:45:56Z","timestamp":1778863556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiometabolic associations of SGLT-2 inhibitors on epicardial adiposity and left ventricular function in type 2 diabetes mellitus with coronary artery disease: insights from Malaysian EpiCAD study"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9242-8802","authenticated-orcid":false,"given":"Wan Ahmad Syazani","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6423-8515","authenticated-orcid":false,"given":"Hasniza","family":"Zaman Huri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5349-0301","authenticated-orcid":false,"given":"Ahmad Syadi","family":"Mahmood Zuhdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4417-0645","authenticated-orcid":false,"given":"Samshol","family":"Sukahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3813-7099","authenticated-orcid":false,"given":"Khairul Nisa\u2019","family":"Ishak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4598-909X","authenticated-orcid":false,"given":"Mohd Nasiruddin","family":"Mansor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1392-8964","authenticated-orcid":false,"given":"Han Yin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8543-3512","authenticated-orcid":false,"given":"Nurakmal","family":"Baharum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azrul Fahmi","family":"Jaharudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8000-9972","authenticated-orcid":false,"given":"Nur Ain Zahidah","family":"Zainudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2380-8171","authenticated-orcid":false,"given":"Aswir Abd","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0500-4452","authenticated-orcid":false,"given":"Norizan","family":"Rosli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6960-0774","authenticated-orcid":false,"given":"Mohd Fairulnizal Md","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3999-1505","authenticated-orcid":false,"given":"Amira Hajirah","family":"Abd Jamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"issue":"10467","key":"53191_CR1","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","volume":"404","author":"B Zhou","year":"2024","unstructured":"Zhou, B. et al. Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: A pooled analysis of 1108 population-representative studies with 141 million participants. Lancet 404 (10467), 2077\u20132093 (2024).","journal-title":"Lancet"},{"issue":"1","key":"53191_CR2","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1186\/s12889-024-19103-7","volume":"24","author":"WS Hasani","year":"2024","unstructured":"Hasani, W. S., Musa, K. I., Cheng, K. Y. & Dass, S. C. Exploring the trend of age-standardized mortality rates from cardiovascular disease in Malaysia: a joinpoint analysis (2010\u20132021). BMC Public. Health. 24 (1), 2519 (2024).","journal-title":"BMC Public. Health"},{"issue":"7","key":"53191_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11306-022-01905-8","volume":"18","author":"S Vasishta","year":"2022","unstructured":"Vasishta, S., Ganesh, K., Umakanth, S. & Joshi, M. B. Ethnic disparities attributed to the manifestation in and response to type 2 diabetes: insights from metabolomics. Metabolomics 18 (7), 45 (2022).","journal-title":"Metabolomics"},{"issue":"1","key":"53191_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/nyas.12098","volume":"1281","author":"RC Ma","year":"2013","unstructured":"Ma, R. C. & Chan, J. C. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann. N Y Acad. Sci. 1281 (1), 64\u201391 (2013).","journal-title":"Ann. N Y Acad. Sci."},{"key":"53191_CR5","doi-asserted-by":"crossref","unstructured":"Xu, Y. et al. Diabetes in China part 1: epidemiology and risk factors. Lancet Public. Health (2024).","DOI":"10.1016\/S2468-2667(24)00250-0"},{"issue":"20","key":"53191_CR6","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","volume":"71","author":"M Packer","year":"2018","unstructured":"Packer, M. Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. J. Am. Coll. Cardiol. 71 (20), 2360\u20132372 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"53191_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4093\/dmj.2015.39.5.405","volume":"39","author":"DK Song","year":"2015","unstructured":"Song, D. K. et al. Increased epicardial adipose tissue thickness in type 2 diabetes mellitus and Obesity. Diabetes Metab. J. 39 (5), 405\u2013413 (2015).","journal-title":"Diabetes Metab. J."},{"issue":"3","key":"53191_CR8","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ihj.2015.08.005","volume":"68","author":"K Meenakshi","year":"2016","unstructured":"Meenakshi, K., Rajendran, M., Srikumar, S. & Chidambaram, S. Epicardial fat thickness: A surrogate marker of coronary artery disease\u2013Assessment by echocardiography. Indian Heart J. 68 (3), 336\u2013341 (2016).","journal-title":"Indian Heart J."},{"issue":"3","key":"53191_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4103\/1995-705X.76801","volume":"11","author":"F Mookadam","year":"2010","unstructured":"Mookadam, F., Goel, R., Alharthi, M. S., Jiamsripong, P. & Cha, S. Epicardial fat and its association with cardiovascular risk: a cross-sectional observational study. Heart Views. 11 (3), 103\u2013108 (2010).","journal-title":"Heart Views"},{"issue":"3","key":"53191_CR10","first-page":"311","volume":"18","author":"HJ Willens","year":"2008","unstructured":"Willens, H. J. et al. Comparison of epicardial and pericardial fat thickness assessed by echocardiography in African American and non-Hispanic White men. Ethn. Dis. 18 (3), 311\u2013316 (2008).","journal-title":"Ethn. Dis."},{"issue":"3","key":"53191_CR11","first-page":"281","volume":"23","author":"SS Salami","year":"2013","unstructured":"Salami, S. S. et al. Race and epicardial fat. Ethn. Dis. 23 (3), 281\u2013285 (2013).","journal-title":"Ethn. Dis."},{"issue":"7","key":"53191_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4070\/kcj.2012.42.7.471","volume":"42","author":"SJ Kim","year":"2012","unstructured":"Kim, S. J. et al. Correlation between epicardial fat thickness by echocardiography and other parameters in obese adolescents. Korean Circ. J. 42 (7), 471\u2013478 (2012).","journal-title":"Korean Circ. J."},{"issue":"04","key":"53191_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/2231-0770.110739","volume":"2","author":"R Shetty","year":"2012","unstructured":"Shetty, R. et al. Correlation of epicardial fat and anthropometric measurements in Asian-Indians: A community based study. Avicenna J. Med. 2 (04), 89\u201393 (2012).","journal-title":"Avicenna J. Med."},{"key":"53191_CR14","doi-asserted-by":"crossref","unstructured":"Mohamed, W. A. S. et al. Ethnic disparities and its association between epicardial adipose tissue thickness and cardiometabolic parameters. Adipocyte. 13(1), 231403217 (2024).","DOI":"10.1080\/21623945.2024.2314032"},{"key":"53191_CR15","doi-asserted-by":"crossref","unstructured":"Sukahri, S., Mohamed, W. A., Zuhdi, A. M., Jamil, A. H. & Huri, H. Z. Associations between ethnicities with eat thickness and cardiac remodeling parameters among Type 2 diabetes patients treated with SGLT-2 inhibitor. Int. J. Cardiol. 417 (2024).","DOI":"10.1016\/j.ijcard.2024.132788"},{"issue":"6","key":"53191_CR16","doi-asserted-by":"publisher","first-page":"868","DOI":"10.4239\/wjd.v5.i6.868","volume":"5","author":"AM Noyes","year":"2014","unstructured":"Noyes, A. M., Dua, K., Devadoss, R. & Chhabra, L. Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease. World J. Diabetes. 5 (6), 868 (2014).","journal-title":"World J. Diabetes"},{"key":"53191_CR17","doi-asserted-by":"publisher","first-page":"204201882092882","DOI":"10.1177\/2042018820928824","volume":"11","author":"RH Christensen","year":"2020","unstructured":"Christensen, R. H., von Scholten, B. J., Lehrskov, L. L., Rossing, P. & J\u00f8rgensen, P. G. Epicardial adipose tissue: An emerging biomarker of cardiovascular complications in type 2 diabetes? Ther. Adv. Endocrinol. Metab. 11, 2042018820928824 (2020).","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"19","key":"53191_CR18","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1161\/CIRCULATIONAHA.111.039586","volume":"126","author":"S Greulich","year":"2012","unstructured":"Greulich, S. et al. Secretory products from epicardial adipose tissue of patients with type 2 diabetes mellitus induce cardiomyocyte dysfunction. Circulation 126 (19), 2324\u20132334 (2012).","journal-title":"Circulation"},{"issue":"2","key":"53191_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/biom12020176","volume":"12","author":"T Salvatore","year":"2022","unstructured":"Salvatore, T. et al. Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes. Biomolecules 12 (2), 176 (2022).","journal-title":"Biomolecules"},{"issue":"1","key":"53191_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-61727-7","volume":"14","author":"B Gustafsson","year":"2024","unstructured":"Gustafsson, B. et al. Determinants of echocardiographic epicardial adipose tissue in a general middle-aged population\u2014The Cardiovascular Risk in Young Finns Study. Sci. Rep. 14 (1), 1\u201314 (2024).","journal-title":"Sci. Rep."},{"issue":"6","key":"53191_CR21","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/oby.22798","volume":"28","author":"G Iacobellis","year":"2020","unstructured":"Iacobellis, G. & Gra-Menendez, S. Effects of dapagliflozin on epicardial fat thickness in patients with type 2 diabetes and obesity. Obesity 28 (6), 1068\u20131074 (2020).","journal-title":"Obesity"},{"key":"53191_CR22","doi-asserted-by":"publisher","first-page":"106322","DOI":"10.1016\/j.ejps.2022.106322","volume":"180","author":"H Yaribeygi","year":"2023","unstructured":"Yaribeygi, H., Maleki, M., Butler, A. E., Jamialahmadi, T. & Sahebkar, A. Sodium-glucose co-transporter-2 inhibitors and epicardial adiposity. Eur. J. Pharm. Sci. 180, 106322 (2023).","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"53191_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/biom12010143","volume":"12","author":"C Llorens-Cebri\u00e0","year":"2022","unstructured":"Llorens-Cebri\u00e0, C., Molina-Van den Bosch, M., Vergara, A., Jacobs-Cach\u00e1, C. & Soler, M. J. Antioxidant roles of SGLT2 inhibitors in the kidney. Biomolecules 12 (1), 143 (2022).","journal-title":"Biomolecules"},{"key":"53191_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejphar.2014.01.040","volume":"727","author":"M Yokono","year":"2014","unstructured":"Yokono, M. et al. SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats. Eur. J. Pharmacol. 727, 66\u201374 (2014).","journal-title":"Eur. J. Pharmacol."},{"key":"53191_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-017-0529-3","volume":"16","author":"GP Fadini","year":"2017","unstructured":"Fadini, G. P. et al. Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with Type 2 diabetes: a randomized placebo-controlled trial. Cardiovasc. Diabetol. 16, 1\u20130 (2017).","journal-title":"Cardiovasc. Diabetol."},{"key":"53191_CR26","unstructured":"Szekeres, Z. J. The Investigation of SGLT2-inhibitors on Cardiometabolic Health (Doctoral dissertation, University of P\u00e9cs (Hungary))."},{"key":"53191_CR27","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.2147\/DMSO.S223629","volume":"12","author":"A Braha","year":"2019","unstructured":"Braha, A. et al. Dynamics of epicardiac fat and heart function in type 2 diabetic patients initiated with SGLT-2 inhibitors. Diabetes Metab. Syndr. Obes. Targets Ther. 12, 2559\u20132566 (2019).","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"53191_CR28","doi-asserted-by":"crossref","unstructured":"Bouchi, R. et al. Luseogliflozin reduces epicardial fat accumulation in patients with Type 2 diabetes: A pilot study. Cardiovasc. Diabetol. 16(1). (2017).","DOI":"10.1186\/s12933-017-0516-8"},{"key":"53191_CR29","doi-asserted-by":"crossref","unstructured":"Sato, T. et al. The effect of dapagliflozin treatment on epicardial adipose tissue volume. Cardiovasc. Diabetol. ;17(1). (2018).","DOI":"10.1186\/s12933-017-0658-8"},{"issue":"8","key":"53191_CR30","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.3390\/cells10082150","volume":"10","author":"W Masson","year":"2021","unstructured":"Masson, W., Lavalle-Cobo, A. & Nogueira, J. P. Effect of SGLT2-inhibitors on epicardial adipose tissue: a meta-analysis. Cells 10 (8), 2150 (2021).","journal-title":"Cells"},{"issue":"1","key":"53191_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-021-02250-9","volume":"21","author":"S Gamaza-Chuli\u00e1n","year":"2021","unstructured":"Gamaza-Chuli\u00e1n, S. et al. Effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on left ventricular remodeling and longitudinal strain: a prospective observational study. BMC Cardiovasc. Disord. 21 (1), 1\u201311 (2021).","journal-title":"BMC Cardiovasc. Disord"},{"issue":"10","key":"53191_CR32","doi-asserted-by":"publisher","first-page":"10887","DOI":"10.21037\/apm-21-2694","volume":"10","author":"L Zhou","year":"2021","unstructured":"Zhou, L., Yang, Y. & Han, W. Sodium-glucose cotransporter-2 inhibitors protect against atrial fibrillation in patients with heart failure. Ann. Palliat. Med. 10 (10), 10887\u201310895 (2021).","journal-title":"Ann. Palliat. Med."},{"key":"53191_CR33","doi-asserted-by":"crossref","unstructured":"Palmiero, G. et al. Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study. Diabetes Res. Clin. Pract. ;200(February). (2023).","DOI":"10.1016\/j.diabres.2023.110686"},{"issue":"10","key":"53191_CR34","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3390\/nu10101383","volume":"10","author":"Z Song","year":"2018","unstructured":"Song, Z., Xiaoli, A. M. & Yang, F. Regulation and metabolic significance of de novo lipogenesis in adipose tissues. Nutrients 10 (10), 1383 (2018).","journal-title":"Nutrients"},{"issue":"15","key":"53191_CR35","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.3390\/nu15153445","volume":"15","author":"A Horwitz","year":"2023","unstructured":"Horwitz, A. & Birk, R. Adipose tissue hyperplasia and hypertrophy in common and syndromic obesity\u2014The case of BBS obesity. Nutrients 15 (15), 3445 (2023).","journal-title":"Nutrients"},{"issue":"10","key":"53191_CR36","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.echo.2015.07.006","volume":"28","author":"Y Hirata","year":"2015","unstructured":"Hirata, Y. et al. Clinical utility of measuring epicardial adipose tissue thickness with echocardiography using a high-frequency linear probe in patients with coronary artery disease. J. Am. Soc. Echocardiogr. 28 (10), 1240\u20131246 (2015).","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"3","key":"53191_CR37","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1210\/jc.2011-2260","volume":"97","author":"J Bolinder","year":"2012","unstructured":"Bolinder, J. et al. Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin. J. Clin. Endocrinol. Metab. 97 (3), 1020\u20131031 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"15","key":"53191_CR38","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.jacc.2019.01.056","volume":"73","author":"CG Santos-Gallego","year":"2019","unstructured":"Santos-Gallego, C. G. et al. Empagliflozin ameliorates adverse left ventricular remodeling in nondiabetic heart failure by enhancing myocardial energetics. J. Am. Coll. Cardiol. 73 (15), 1931\u20131944 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"53191_CR39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12933-024-02539-x","volume":"23","author":"C Morciano","year":"2024","unstructured":"Morciano, C. et al. SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives. Cardiovasc. Diabetol. 23 (1), 449 (2024).","journal-title":"Cardiovasc. Diabetol."},{"key":"53191_CR40","doi-asserted-by":"crossref","unstructured":"Theofilis, P. et al. Sodium-glucose cotransporter 2 inhibitors and changes in epicardial adipose tissue: A systematic literature review and meta-analysis. Curr. Vasc. Pharmacol. (2025).","DOI":"10.2174\/0115701611330060241204062248"},{"issue":"1","key":"53191_CR41","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12933-023-02091-0","volume":"22","author":"F Cinti","year":"2023","unstructured":"Cinti, F. et al. Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes. Cardiovasc. Diabetol. 22 (1), 349 (2023).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"53191_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13098-017-0275-4","volume":"9","author":"S Yagi","year":"2017","unstructured":"Yagi, S. et al. Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus. Diabetol. Metab. Syndr. 9 (1), 78 (2017).","journal-title":"Diabetol. Metab. Syndr."},{"issue":"10","key":"53191_CR43","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.acvd.2019.06.005","volume":"112","author":"D Arangalage","year":"2019","unstructured":"Arangalage, D. et al. Epicardial adipose tissue volume is associated with left ventricular remodelling in calcific aortic valve stenosis. Arch. Cardiovasc. Dis. 112 (10), 594\u2013603 (2019).","journal-title":"Arch. Cardiovasc. Dis."},{"issue":"13","key":"53191_CR44","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/eurheartj\/eht099","volume":"36","author":"N Venteclef","year":"2015","unstructured":"Venteclef, N. et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur. Heart J. 36 (13), 795\u2013805 (2015).","journal-title":"Eur. Heart J."},{"issue":"11","key":"53191_CR45","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.3390\/life13112128","volume":"13","author":"N Laera","year":"2023","unstructured":"Laera, N. et al. Impact of immunity on coronary artery disease: an updated pathogenic interplay and potential therapeutic strategies. Life 13 (11), 2128 (2023).","journal-title":"Life"},{"issue":"3","key":"53191_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jacc.2011.01.048","volume":"58","author":"Y Hirata","year":"2011","unstructured":"Hirata, Y. et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J. Am. Coll. Cardiol. 58 (3), 248\u2013255 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"53191_CR47","doi-asserted-by":"crossref","unstructured":"Di Giacomo Barbagallo, F. et al. Assessment of N\/L ratio and subclinical atherosclerosis in FH subjects with or without LDLR mutation. J. Endocr. Soc. 8, bvag001 (2026).","DOI":"10.1210\/jendso\/bvag001"},{"issue":"1","key":"53191_CR48","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12933-024-02298-9","volume":"23","author":"BJ Kasperova","year":"2024","unstructured":"Kasperova, B. J. et al. Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure. Cardiovasc. Diabetol. 23 (1), 223 (2024).","journal-title":"Cardiovasc. Diabetol."},{"issue":"20","key":"53191_CR49","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1161\/01.CIR.0000099542.57313.C5","volume":"108","author":"T Mazurek","year":"2003","unstructured":"Mazurek, T. et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108 (20), 2460\u20132466 (2003).","journal-title":"Circulation"},{"issue":"23","key":"53191_CR50","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.3390\/ijms20235989","volume":"20","author":"AC Villasante Fricke","year":"2019","unstructured":"Villasante Fricke, A. C. & Iacobellis, G. Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk. Int. J. Mol. Sci. 20 (23), 5989 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"53191_CR51","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12933-021-01385-5","volume":"20","author":"A Natali","year":"2021","unstructured":"Natali, A., Nesti, L., Trico, D. & Ferrannini, E. Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence. Cardiovasc. Diabetol. 20 (1), 196 (2021).","journal-title":"Cardiovasc. Diabetol."},{"key":"53191_CR52","doi-asserted-by":"publisher","first-page":"e06","DOI":"10.15420\/cfr.2022.25","volume":"9","author":"MT Oduah","year":"2023","unstructured":"Oduah, M. T., Sundaram, V. & Reddy, Y. N. Epicardial fat in heart failure with preserved ejection fraction: bad actor or just lying around? Cardiac Fail. Rev. 9, e06 (2023).","journal-title":"Cardiac Fail. Rev."},{"issue":"1","key":"53191_CR53","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12933-018-0735-7","volume":"17","author":"DH Cho","year":"2018","unstructured":"Cho, D. H. et al. Association between epicardial adipose tissue, high-sensitivity C-reactive protein and myocardial dysfunction in middle-aged men with suspected metabolic syndrome. Cardiovasc. Diabetol. 17 (1), 95 (2018).","journal-title":"Cardiovasc. Diabetol."},{"issue":"5","key":"53191_CR54","first-page":"e84184","volume":"17","author":"AA Osman Mohamed","year":"2025","unstructured":"Osman Mohamed, A. A. et al. The Role of Epicardial Fat Thickness and B-type Natriuretic Peptide (BNP)\/N-terminal Pro B-type Natriuretic Peptide (NT-proBNP) in Heart Failure Risk Stratification: A Systematic Review. Cureus 17 (5), e84184 (2025).","journal-title":"Cureus"},{"issue":"1","key":"53191_CR55","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12933-025-02933-z","volume":"24","author":"ON Koutcha","year":"2025","unstructured":"Koutcha, O. N. et al. Epicardial adipose tissue volume and arterial stiffness in people living with diabetes: the METAB-CV-PWV study. Cardiovasc. Diabetol. 24 (1), 400 (2025).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"53191_CR56","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12933-025-02769-7","volume":"24","author":"S Scilletta","year":"2025","unstructured":"Scilletta, S. et al. Cardiovascular risk profile in subjects with diabetes: Is SCORE2-Diabetes reliable? Cardiovasc. Diabetol. 24 (1), 222 (2025).","journal-title":"Cardiovasc. Diabetol."},{"issue":"8","key":"53191_CR57","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.jdiacomp.2017.05.007","volume":"31","author":"LZ Kiss","year":"2017","unstructured":"Kiss, L. Z. et al. Signs of subclinical atherosclerosis in asymptomatic patients at increased risk of type 2 diabetes mellitus. J. Diabetes Complicat. 31 (8), 1293\u20131298 (2017).","journal-title":"J. Diabetes Complicat."},{"issue":"11","key":"53191_CR58","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2459\/JCM.0000000000001557","volume":"24","author":"AV Mattioli","year":"2023","unstructured":"Mattioli, A. V., Coppi, F., Bucciarelli, V. & Gallina, S. Cardiovascular risk stratification in young women: the pivotal role of pregnancy. J. Cardiovasc. Med. 24 (11), 793\u2013797 (2023).","journal-title":"J. Cardiovasc. Med."},{"key":"53191_CR59","first-page":"216","volume":"113","author":"L Askin","year":"2019","unstructured":"Askin, L., Tanr\u0131verdi, O., Tibilli, H. & Turkmen, S. New method improves the evaluation of subclinical left ventricular dysfunction in type 2 diabetes mellitus. Arq. Bras. Cardiol. 113, 216\u2013217 (2019).","journal-title":"Arq. Bras. Cardiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53191-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53191-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53191-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:01:22Z","timestamp":1784077282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53191-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53191"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53191-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8415238\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":". The study received approval from the Medical Ethics Committee of UMMC (MREC ID No: 2020117-9213) and was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines.  Written informed consent was obtained from all participants prior to enrolment.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22180"}}